Retour sur lavenir.net
   CMB.TECH 13.720 € (+0,59 %)     ARGENX SE 751.200 € (-3,15 %)     AB INBEV 73.480 € (-0,57 %)     UCB 215.300 € (-14,19 %)     UMICORE 21.100 € (+4,77 %)     VGP 84.400 € (-1,86 %)     WDP 22.480 € (-0,53 %)     DEME GROUP 166.600 € (+1,46 %)     SOLVAY 27.040 € (+1,12 %)     KBC 122.750 € (+1,53 %)     GBL 78.700 € (+0,51 %)     ELIA GROUP 127.800 € (-0,23 %)     BEKAERT 39.200 € (-6,56 %)     ONTEX GROUP 2.240 € (-6,47 %)     AGFA-GEVAERT 0.383 € (-0,65 %)     MELEXIS 68.350 € (+2,01 %)     XIOR 28.150 € (+0,72 %)     AGEAS 71.700 € (+1,13 %)     ONWARD MEDICAL 2.375 € (+0,21 %)     PROXIMUS 6.325 € (-0,63 %)     SYENSQO 77.900 € (+9,03 %)     ACKERMANS V.HAAREN 268.600 € (+1,97 %)     BPOST 1.530 € (+0,13 %)     LOTUS BAKERIES 11 380.000 € (+0,71 %)     RECTICEL 11.980 € (-1,32 %)     D'IETEREN GROUP 183.800 € (+1,21 %)     IBA 16.000 € (+0,38 %)     TESSENDERLO 21.000 € (+0,96 %)     SHURGARD 25.750 € (+0,59 %)     NYRSTAR 0.063 € (+5,00 %)     KINEPOLIS GROUP 41.150 € (-0,72 %)     AZELIS GROUP 11.680 € (+2,55 %)     JENSEN-GROUP 83.200 € (+0,24 %)     AEDIFICA 71.200 € (-0,28 %)     SOFINA 243.400 € (+0,50 %)     KBC ANCORA 87.400 € (+1,51 %)     FAGRON 23.900 € (+2,14 %)     RETAIL ESTATES 67.100 € (+1,36 %)     BARCO 7.965 € (+0,70 %)     CARE PROPERTY INV. 12.760 € (0,00 %)     COLRUYT 39.360 € (+1,39 %)     EVS 27.300 € (-1,09 %)     CENERGY 21.200 € (+1,24 %)     ORANGE BELGIUM 22.200 € (0,00 %)     DECEUNINCK 2.265 € (+2,49 %)     ECONOCOM GROUP 1.395 € (+0,36 %)     NYXOAH 1.242 € (-0,32 %)     ASCENCIO 52.200 € (+0,19 %)     CAMPINE 212.000 € (-0,47 %)     GIMV 44.550 € (+0,34 %)     MONTEA 68.200 € (-0,15 %)     TINC 11.440 € (0,00 %)     BQUE NAT. BELGIQUE 370.000 € (+0,27 %)     BREDERODE 103.000 € (+0,59 %)     TUBIZE-FIN 189.400 € (-11,50 %)     WERELDHAVE BELGIUM 53.000 € (0,00 %)     EKOPAK 3.600 € (-2,57 %)     TITAN S.A. 52.000 € (+0,68 %)     OPTION 4.000 € (-11,31 %)     CELYAD ONCOLOGY 0.271 € (-0,73 %)  
   STIF 52.450 € (+2,44 %)     FDJ UNITED 22.110 € (-3,87 %)     EMEIS 14.510 € (+4,24 %)     AYVENS 12.240 € (+5,79 %)     OPMOBILITY 13.110 € (+2,82 %)     EXOSENS 57.800 € (-0,34 %)     BANIJAY GROUP 8.660 € (+1,88 %)     IMERYS 24.080 € (+11,07 %)     BNP PARIBAS ACT.A 108.680 € (+1,65 %)     STMICROELECTRONICS 45.010 € (+4,93 %)     MICHELIN 34.780 € (+1,28 %)     SAINT GOBAIN 76.840 € (+1,69 %)     AIRBUS 203.800 € (-2,91 %)     AIR LIQUIDE 172.960 € (+0,86 %)     VINCI 123.750 € (+4,61 %)     CAPGEMINI 104.000 € (-2,89 %)     UBISOFT ENTERTAIN 5.768 € (+3,26 %)     B.COM.PORTUGUES 1.056 € (+3,83 %)     THALES 243.600 € (-0,73 %)     ARCELORMITTAL SA 58.000 € (+0,38 %)     ING GROEP N.V. 30.115 € (+4,75 %)     TOTALENERGIES 75.720 € (-0,15 %)     TRIGANO 154.700 € (+1,98 %)     RENAULT 27.860 € (-0,18 %)     ASM INTERNATIONAL 787.000 € (+9,31 %)     ASML HOLDING 1 423.400 € (+4,49 %)     PHARMING GROUP 0.846 € (-22,95 %)     POXEL 0.201 € (+0,35 %)     DSM FIRMENICH AG 93.500 € (+12,14 %)     AKZO NOBEL 61.420 € (+1,09 %)     STELLANTIS NV 4.920 € (-6,84 %)     FORVIA 9.556 € (+3,40 %)     Vusion 138.300 € (+1,99 %)     NX FILTRATION 3.220 € (+0,78 %)     GALP ENERGIA-NOM 19.865 € (-0,65 %)     SAFRAN 340.000 € (+0,06 %)     THEON INTERNAT 32.440 € (-1,46 %)     HEINEKEN 79.520 € (-0,62 %)     EDENRED 28.760 € (-0,10 %)     VALNEVA 2.175 € (-1,58 %)     SPIE 47.220 € (+0,17 %)     AUBAY 57.600 € (-2,37 %)     BE SEMICONDUCTOR 196.300 € (+3,59 %)     SANOFI 72.990 € (-8,67 %)     ESSILORLUXOTTICA 165.100 € (0,00 %)     EUTELSAT COMMUNIC. 2.003 € (-3,21 %)     EXOR NV 68.900 € (-0,86 %)     LEGRAND 130.400 € (+1,32 %)     SCHNEIDER ELECTRIC 281.900 € (+9,77 %)     SEMCO TECHNOLOGIES 40.500 € (+2,40 %)     ORANGE 17.078 € (-1,85 %)     KPN KON 4.192 € (-0,45 %)     CARREFOUR 16.080 € (+2,49 %)     WOLTERS KLUWER 70.200 € (-5,26 %)     ARKEMA 61.900 € (+6,63 %)     EURONEXT 150.000 € (-0,73 %)     IPSEN 162.200 € (-0,92 %)     S.E.B. 59.450 € (-0,34 %)     PERNOD RICARD 68.540 € (+0,38 %)     REXEL 36.120 € (+3,41 %)  
News Réglementées
30/07/2026 07:30

Symrise reports solid H1 2026 performance with accelerating growth momentum in Q2

EQS-News: Symrise AG / Key word(s): Half Year Results
Symrise reports solid H1 2026 performance with accelerating growth momentum in Q2

30.07.2026 / 07:30 CET/CEST
The issuer is solely responsible for the content of this announcement.


Press release

Holzminden, July 30, 2026

Symrise reports solid H1 2026 performance with accelerating growth momentum in Q2
  • Organic sales growth accelerated to 4.5% in Q2 2026 (2.0% in H1 2026)
  • Adjusted EBITDA of €553 million and 21.8% adjusted EBITDA margin
  • Adjusted Business Free Cash Flow margin up 450 bps to 13.7% of sales
  • Planned acquisition of Floral Concept will strengthen position in Premium Naturals
  • Full year 2026 outlook reaffirmed

Symrise AG, a leading global supplier of flavors and fragrances, as well as cosmetic and functional ingredients, delivered a solid performance in the first half of 2026, with organic sales growth improving through the second quarter despite a still soft macroeconomic environment. Accelerated organic sales growth was supported by continued strength in Food & Beverage, Consumer Fragrance and Aroma Molecules, well supported by rebounding momentum in North America and Asia Pacific.

For the first six months of 2026, Symrise reported sales of €2,539 million and an organic sales growth of 2.0%. Organic sales growth accelerated to 4.5% in the second quarter. H1 adjusted EBITDA was €553 million with an adjusted EBITDA margin of 21.8%. Profitable sales growth and efficiency measures supported earnings development, partially mitigated by investments in the ONE SYM transformation and logistics costs driven by ongoing geopolitical tensions in the Middle East. Adjusted Business Free Cash Flow was up by 450 bps and reached €347 million, corresponding to a margin of 13.7%.

Symrise continued to execute its ONE Symrise Strategy and further sharpened portfolio quality by submitting a binding offer for Floral Concept. The envisaged acquisition will strengthen Symrise’s position in Premium Naturals within Fine Fragrance. At the same time, the company accelerated the next phase of its ONE SYM Transformation program to drive faster progress towards higher profitable organic sales growth. Symrise is increasingly focused on accelerating the delivery of efficiencies and strategically reinvesting these savings into growth opportunities across the business.

Dr. Jean Yves Parisot, CEO of Symrise AG, said: “We saw increasing momentum in the second quarter, driven by disciplined execution across our businesses and strong demand in Food & Beverage, Consumer Fragrance and Aroma Molecules. We also will strengthen our portfolio through the planned acquisition of Floral Concept. We will leverage our proven Naturals capabilities, built through the acquisition of Diana and successfully established in Food & Beverage, to further expand our offering in Fine Fragrance and create differentiated solutions for our customers. At the same time, we continued to accelerate the next phase of our ONE SYM Transformation to further enhance commercial excellence, innovation and digitalization to support faster profitable growth. Based on our first half performance and current momentum, we remain confident in delivering our 2026 outlook and creating durable long-term value.”

Segment Performance

Taste, Nutrition & Health

In the second quarter of 2026, the Taste, Nutrition & Health segment delivered organic sales growth of 4.9%. Reported sales increased to €782 million compared with €748 million in the prior-year quarter.

  • The Food & Beverage division delivered market-leading mid-single-digit organic sales growth, driven by high-single-digit organic sales growth in Savory and Naturals, and mid-single-digit organic sales growth in Sweet.
  • The Pet Food division reported a slight organic sales decline, reflecting continued Nutrition price normalization.

For the first half of 2026, Taste, Nutrition & Health achieved organic sales growth of 3.2%. Reported sales amounted to €1,530 million compared with €1,527 million in the prior-year period. The segment increased adjusted EBITDA to €375 million and improved the adjusted EBITDA margin by 10 basis points to 24.5%.

Scent & Care

The Scent & Care segment achieved organic sales growth of 3.8% in the second quarter of 2026. Reported sales increased to €509 million compared with €489 million in the prior-year quarter.

  • The Fragrance division delivered mid-single-digit organic sales growth. Fine Fragrance reported a mid-single-digit decline driven by high comparables with continuing high demand and project vitality. Consumer Fragrance delivered high-single-digit organic sales growth.
  • The Care & Wellness division reported a low-single-digit decline but sequentially improved over Q1, with UV filters continuing to decline mid-single-digit.
  • The Aroma Molecules division delivered high-single-digit organic sales growth on favorable comparables in demanding inflation environment. Performance was driven by double-digit organic sales growth in Specialty Fragrance Ingredients and Menthol.

For the first half of 2026, Scent & Care achieved stable organic sales. Reported sales were €1,009 million compared with €1,026 million in the prior-year period. Adjusted EBITDA was €178 million with an adjusted EBITDA margin of 17.7%, impacted by portfolio changes and mix effects as well as increased freight and logistics costs in relation to the geopolitical situation in the Middle East.
 

Advancing ONE Symrise Strategy and Accelerating ONE SYM Transformation

As part of its active portfolio management approach, Symrise announced the planned acquisition of Floral Concept, a premium naturals house based in Saint-Cézaire-sur-Siagne, Pays de Grasse, France. The transaction will strengthen the company's position in the attractive premium naturals market and will create an opportunity to extend its success story of naturals in flavors into fragrances. This contemplated acquisition thus matches the company’s strategy of focusing on differentiated, higher value growth opportunities.

Symrise continued to accelerate the execution of its ONE SYM Transformation program. The Company is strengthening its value chain through prioritized commercial excellence, innovation, operations and supply chain management. At the same time, Symrise is building a more scalable operating structure through standardized processes, clearer process ownership and increased digitalization across the organization.

The company reinvests efficiency gains generated by its transformation program to support future growth opportunities while maintaining its margin ambitions.


Outlook for 2026

Symrise reaffirms its full year 2026 outlook and continues to expect:

  • Organic sales growth of 2% to 4%
  • Adjusted EBITDA margin of 21.5% to 22.5%
  • Adjusted Business Free Cash Flow margin above 14%

The outlook is underpinned by the acceleration of our ONE SYM Transformation program and supported by strong project vitality with key customers, a solid pipeline of new solutions, and resilience in our core end markets.

About Symrise

Symrise is a global supplier of flavors and fragrances, cosmetic base and active ingredients, and functional ingredients. Its customers include manufacturers of perfume, cosmetics, food and beverages, as well as the pharmaceutical industry and producers of dietary supplements and pet food.

With sales of around €4.9 billion in the 2025 financial year, the company is one of the world’s leading providers. Headquartered in Holzminden, Germany, the Group has more than 100 sites in Europe, Africa and the Middle East, Asia, North America and Latin America.

Together with its customers, Symrise develops new ideas and market-ready concepts for products that have become an indispensable part of everyday life. Economic success and corporate responsibility are inextricably linked. Symrise – always inspiring more...

www.symrise.com 

 

 
Contact media:
 
Marc Pönitz
 
Contact investors:
 
Rene Weinberg
Phone: +49 (0)5531 90-1721Phone: +49 (0)5531 90-1879
E-mail: marc.poenitz@symrise.cpmE-mail: rene.weinberg@symrise.com
  
Social Media: 
twitter.com/symriseaglinkedin.com/company/symrise
youtube.com/agsymrisexing.com/companies/symrise
instagram.com/symriseaginstagram.com/finefragrancestories_bySymrise
instagram.com/symrise.ciBlog: https://alwaysinspiringmore.com

 

 



30.07.2026 CET/CEST Dissemination of a Corporate News, transmitted by EQS News - a service of EQS Group.
The issuer is solely responsible for the content of this announcement.

The EQS Distribution Services include Regulatory Announcements, Financial/Corporate News and Press Releases.
View original content: EQS News


Language:English
Company:Symrise AG
Mühlenfeldstraße 1
37603 Holzminden
Germany
Phone:+49 (0)5531 90 0
E-mail:ir@symrise.com
Internet:www.symrise.com
ISIN:DE000SYM9999, DE000SYM7787, DE000SYM7704
WKN:SYM999
Indices:DAX
Listed:Regulated Market in Frankfurt (Prime Standard); Regulated Unofficial Market in Dusseldorf, Hamburg, Hanover, Munich, Stuttgart, Tradegate BSX
LEI Code:529900D82I6R9601CF26
EQS News ID:2373852

 
End of NewsEQS News Service

2373852  30.07.2026 CET/CEST

Source : Webdisclosure.com

© 2026 Tous droits réservés
Cotations différées d'au moins 15 minutes (Paris, Amsterdam, Bruxelles, Lisbonne).
Cotations à la clôture (Francfort, New-York, Londres, Zurich).
Flux de cotations : Euronext (Places Euronext et Cours des Devises).
Bourse : technologie Cote Boursière